Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)—a translational analysis of the prospective WSG PlanB trial

Autor: Cornelia Kolberg-Liedtke, Gluz Oleg, Heinisch Fred, Feuerhake Friedrich, Kreipe Hans, Clemens Michael, Nuding Benno, Malter Wolfram, Reimer Toralf, Wuerstlein Rachel, Graeser Monika, Shak Steve, Nitz Ulrike, Kates Ronald, Christgen Matthias, Harbeck Nadia

Publikováno v: Breast Cancer Research, Vol 22, Iss 1, Pp 1-9 (2020)

Abstract Background The presence of tumor-infiltrating lymphocytes has been associated with prognosis and chemotherapy response, particularly in high-risk breast cancer subtypes. There is limited data so far as to (i) how tumor-infiltrating lymphocyt

Externí odkaz: https://doaj.org/article/8ea47de415e540d2b018174d9ff366c8

Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial.

Autor: Kolberg-Liedtke C; Gynäkologie mit Brustzentrum, Charité-Universitätsmedizin Berlin, Berlin, Germany. cornelia.kolberg-liedtke@charite.de., Gluz O; West German Study Group, Mönchengladbach, Germany.; Ev. Hospital Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany., Heinisch F; Institute of Pathology, Medical School Hannover, Hannover, Germany., Feuerhake F; Department of Oncology, Clinics Mutterhaus der Borromaeerinnen, Trier, Germany., Kreipe H; Department of Oncology, Clinics Mutterhaus der Borromaeerinnen, Trier, Germany., Clemens M; Department of Gynecology and Obstetrics, Evangelical Hospital, Bergisch Gladbach, Germany., Nuding B; Department of Gynaecology and Obstertrics, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Malter W; Department of Gynaecology and Obstetrics, University Clinics Rostock, Rostock, Germany., Reimer T; Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany., Wuerstlein R; West German Study Group, Mönchengladbach, Germany.; Genomic Health, Inc., Redwood City, CA, USA., Graeser M; West German Study Group, Mönchengladbach, Germany.; Ev. Hospital Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany., Shak S; Genomic Health, Inc., Redwood City, CA, USA., Nitz U; West German Study Group, Mönchengladbach, Germany.; Ev. Hospital Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany., Kates R; West German Study Group, Mönchengladbach, Germany., Christgen M; Department of Oncology, Clinics Mutterhaus der Borromaeerinnen, Trier, Germany., Harbeck N; West German Study Group, Mönchengladbach, Germany.; Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany.

Publikováno v: Breast cancer research : BCR [Breast Cancer Res] 2020 May 14; Vol. 22 (1), pp. 47. Date of Electronic Publication: 2020 May 14.